Gelnique FDA Approval History
FDA Approved: Yes (First approved January 27, 2009)
Brand name: Gelnique
Generic name: oxybutynin hydrochloride
Dosage form: Topical Gel
Previous Name: OTG
Company: Watson Pharmaceuticals, Inc.
Treatment for: Overactive Bladder
Gelnique (oxybutynin chloride) Gel is a transdermal antispasmodic which is applied to the skin once daily for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and frequency.
Development Timeline for Gelnique
|Jan 28, 2009||Watson's Gelnique (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder|
|May 28, 2008||Watson Announces Oxybutynin Topical Gel NDA Accepted for Filing byFDA for the Treatment of Overactive Bladder|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.